These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11977864)

  • 1. Role of NCCLS in antimicrobial susceptibility testing and monitoring.
    Ginocchio CC
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S7-11. PubMed ID: 11977864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program.
    Jones RN;
    Arch Pathol Lab Med; 2001 Oct; 125(10):1285-9. PubMed ID: 11570902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards.
    Fuchs PC; Barry AL; Brown SD
    Antimicrob Agents Chemother; 2002 Feb; 46(2):398-401. PubMed ID: 11796348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The era of antimicrobial resistance-implications for the clinical laboratory.
    Low DE
    Clin Microbiol Infect; 2002; 8 Suppl 3():9-20; discussion 33-5. PubMed ID: 12519345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(7):152-4. PubMed ID: 14985653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH; Swenson JM; Tenover FC; Ferraro MJ; Hindler JA; Murray PR
    J Clin Microbiol; 1994 Oct; 32(10):2448-59. PubMed ID: 7814481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).
    Jones RN; Mutnick AH; Varnam DJ
    J Clin Microbiol; 2002 Nov; 40(11):4332-3. PubMed ID: 12409423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.
    Klugman KP; Low DE; Metlay J; Pechere JC; Weiss K
    Int J Antimicrob Agents; 2004 Nov; 24(5):411-22. PubMed ID: 15519470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
    Mohd Nasir MD; Parasakthi N
    Malays J Pathol; 2004 Jun; 26(1):29-33. PubMed ID: 16190104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
    Liu PY; Shi ZY; Tung KC; Shyu CL; Chan KW; Liu JW; Wu ZY; Kao CC; Huang YC; Lin CF
    J Infect Dev Ctries; 2014 Mar; 8(3):289-96. PubMed ID: 24619258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.
    Kiehlbauch JA; Hannett GE; Salfinger M; Archinal W; Monserrat C; Carlyn C
    J Clin Microbiol; 2000 Sep; 38(9):3341-8. PubMed ID: 10970381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing (AST): a review of changing trends, quality control guidelines, test accuracy, and recommendation for the testing of beta-lactam drugs.
    Jones RN
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):1-24. PubMed ID: 6368105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods.
    Chaitram JM; Jevitt LA; Lary S; Tenover FC;
    J Clin Microbiol; 2003 Jun; 41(6):2372-7. PubMed ID: 12791851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for antimicrobial susceptibility testing of fastidious aerobic bacteria.
    Hindler J
    Am J Med Technol; 1983 Nov; 49(11):761-7. PubMed ID: 6418005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Vázquez M; Marín M; Nicola F; Radice M; Galas M; Pasterán F; Bantar C; Casellas JM; Kovensky Pupko J; Couto E; Goldberg M; Lopardo H; Gutkind G; Soloaga R;
    Rev Argent Microbiol; 2005; 37(1):57-66. PubMed ID: 15991480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugs.
    Gums JG
    Int J Antimicrob Agents; 2003 Oct; 22 Suppl 1():S3-13; discussion S25-6. PubMed ID: 14512220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.